A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors

NCT05764915 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Due to the change in study plan and not due to safety reasons

Conditions

Advanced Solid Tumor

Interventions

DRUG: RGT-264 phosphate tablets

Sponsor

Regor Pharmaceuticals Inc.